MolNFT v1 · #122729 · protein
Structure of apo oxa-143 carbapenemase
5IY2 · Beta-lactamase oxa-143: “Structure of apo oxa-143 carbapenemase”. X-ray diffraction, 3 pockets (best druggability 0.59). MolNFT v1 #122729 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 5IY2
- Type
- protein
- Length
- 481 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Beta-lactamase oxa-143
- UniProt
- D0UHC8
- Pockets
- 3 · best druggability 0.59
Structure
x-ray diffraction · 2 distinct chains · 42% helix, 22% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Beta-lactamase oxa-143 | protein | 241 | 42% helix, 22% strand | D0UHC8 |
| B | Beta-lactamase oxa-143 | protein | 240 | 42% helix, 22% strand | D0UHC8 |
Ligands and binding sites
- GOL · Glycerol · additive · 2 copies · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 120 | 0.59 | 0.85 | 21 | empty |
| 2 | 283 | 0.58 | 0.77 | 38 | GOL |
| 3 | 177 | 0.46 | 0.75 | 31 | empty |
Interfaces
1 interface between chains.
- A–B · 511 Ų buried · 0 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 2 modified (carboxylation).
Compared structures
- 5IY2 · Structure of apo OXA-143 carbapenemase · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt D0UHC8
- Elsewhere: RCSB PDB 5IY2 · PDBe 5IY2 · UniProt D0UHC8
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.